TrialDiabetes & vascular disease research

Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial.

David Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.